FR2270891A2 - Vaccines by glutaraldehyde detoxification - especially multivalent vaccines e.g. against tetanus and diphtheria - Google Patents

Vaccines by glutaraldehyde detoxification - especially multivalent vaccines e.g. against tetanus and diphtheria

Info

Publication number
FR2270891A2
FR2270891A2 FR7416936A FR7416936A FR2270891A2 FR 2270891 A2 FR2270891 A2 FR 2270891A2 FR 7416936 A FR7416936 A FR 7416936A FR 7416936 A FR7416936 A FR 7416936A FR 2270891 A2 FR2270891 A2 FR 2270891A2
Authority
FR
France
Prior art keywords
vaccines
product
glutaraldehyde
diphtheria
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7416936A
Other languages
English (en)
French (fr)
Other versions
FR2270891B2 (online.php
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Priority to FR7416936A priority Critical patent/FR2270891A2/fr
Publication of FR2270891A2 publication Critical patent/FR2270891A2/fr
Application granted granted Critical
Publication of FR2270891B2 publication Critical patent/FR2270891B2/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7416936A 1974-05-15 1974-05-15 Vaccines by glutaraldehyde detoxification - especially multivalent vaccines e.g. against tetanus and diphtheria Granted FR2270891A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7416936A FR2270891A2 (en) 1974-05-15 1974-05-15 Vaccines by glutaraldehyde detoxification - especially multivalent vaccines e.g. against tetanus and diphtheria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7416936A FR2270891A2 (en) 1974-05-15 1974-05-15 Vaccines by glutaraldehyde detoxification - especially multivalent vaccines e.g. against tetanus and diphtheria

Publications (2)

Publication Number Publication Date
FR2270891A2 true FR2270891A2 (en) 1975-12-12
FR2270891B2 FR2270891B2 (online.php) 1978-05-26

Family

ID=9138897

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7416936A Granted FR2270891A2 (en) 1974-05-15 1974-05-15 Vaccines by glutaraldehyde detoxification - especially multivalent vaccines e.g. against tetanus and diphtheria

Country Status (1)

Country Link
FR (1) FR2270891A2 (online.php)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470773A1 (online.php) * 1979-11-28 1981-06-12 Pasteur Institut
JPS56152495A (en) * 1980-04-04 1981-11-26 Smith Kline Rit E.coli fever stable entrotoxin drrivative and manufacture
FR2532850A1 (fr) * 1982-09-15 1984-03-16 Pasteur Institut Conjugues immunogenes entre un haptene et une molecule porteuse derivee d'une toxine, les vaccins les composant et procede pour leur obtention
WO1997002838A1 (es) * 1995-07-12 1997-01-30 Francisco Javier Martin Oncina Vacunas polimerizadas

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470773A1 (online.php) * 1979-11-28 1981-06-12 Pasteur Institut
EP0030496B1 (fr) * 1979-11-28 1983-07-13 Institut Pasteur Composé polypeptidique thiolé provenant d'un fragment de la toxine tétanique, son procédé d'obtention et ses applications
JPS56152495A (en) * 1980-04-04 1981-11-26 Smith Kline Rit E.coli fever stable entrotoxin drrivative and manufacture
EP0037522A3 (en) * 1980-04-04 1982-05-19 Smith Kline - Rit Societe Anonyme Dite: Derivatives of the heat stable enterotoxin of escherichia coli, and their preparation
FR2532850A1 (fr) * 1982-09-15 1984-03-16 Pasteur Institut Conjugues immunogenes entre un haptene et une molecule porteuse derivee d'une toxine, les vaccins les composant et procede pour leur obtention
WO1997002838A1 (es) * 1995-07-12 1997-01-30 Francisco Javier Martin Oncina Vacunas polimerizadas
ES2108614A1 (es) * 1995-07-12 1997-12-16 Oncina Fco Javier Martin Vacunas polimerizadas.

Also Published As

Publication number Publication date
FR2270891B2 (online.php) 1978-05-26

Similar Documents

Publication Publication Date Title
EP0024493A3 (en) Pneumococcal capsular polysaccharide, preparation thereof, multivalent pneumococcal vaccine and method of inducing active immunity
DK0550477T3 (da) Inaktiveret Mycoplasma hyopneumoniae-bakterin og fremgangsmåde til anvendelse deraf
NO950739D0 (no) Vaksiner mot gruppe C Neisseria Meningtidis
ES442892A1 (es) Un procedimiento para la produccion de una vacuna que cuandose inyecta en gatos es capaz de inmunizarlos contra el feli-ne calicivirus.
ES469225A1 (es) Procedimiento para potenciar la accion de las vacunas.
GB1492596A (en) Tetanus toxoid and process for its manufacture
ES2100893T3 (es) Procedimiento de preparacion de una vacuna o de un agente toxico.
ATE107516T1 (de) Pasteurella-impfstoff.
EP0090660A3 (en) Neisseria gonorrhoeae vaccine
DK0603386T3 (da) Parenteral immunisering mod rotavirus
GB928807A (en) Combined poliomyelitis-diphtheria-tetanus-pertussis antigen and methods for its manufacture
ES8502339A1 (es) Procedimiento de obtencion de una vacuna para ejercer la formacion de anticuerpo de fosfato de poliribosilribitol (prp) en un animal de sangre caliente
EP0636030A4 (en) VACCINE AGAINST THE -I BACTERIAL OXIDE (PASTEURELLIA HAEMOLYTICA).
Agnese Combined immunization against diphtheria, tetanus and pertussis in newborn infants, duration of antibody levels; antibody titers after booster dose; effect of passive immunity to diphtheria on active immunization with diphtheria toxoid
SU324772A1 (ru) Способ получени столбн чного анатоксина
FR2230346A1 (en) Inactivating microorganisms with ethyleneimine - in the production of antigens or immunogens for pharmaceutical purposes
Ungar Enhancement of the antigenic activity of toxoids by sympathomimetic drugs
ES476147A1 (es) Un metodo de obtencion de un complejo inmunogenico antigeni-co
SU1580617A1 (ru) Способ получения вакцины против вируса гриппа
Baeva et al. Effect of duration of the intervals between immunization with DPT vaccine on the serological indices in children
Miura Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on the immunity of pertussis, diphtheria and tetanus. 2. Observations during the intervals from the initial immunization to the time of booster dose and the effects of successive immunization
CS189587B2 (en) Method of preparing viruses strains which stimulate natural defensive ability of microorganisms without contemporary action as antigen
Ribero et al. Length of Tetanus Immunity in Relation to the Number of Vaccine Doses.
SU1218526A1 (ru) Способ получения мелиоидозной преципитирующей сыворотки
HUT57064A (en) New-type immunizing process for profilacting deseases of domestic animals produced by mortal agents

Legal Events

Date Code Title Description
TP Transmission of property
TP Transmission of property